These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36107845)

  • 21. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
    Sturges A; Butt AL; Lai JE; Chodosh J
    Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.
    Kim BH; Kim MK; Wee WR; Oh JY
    Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2569-73. PubMed ID: 24006080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R; Ambastha A; Kumar S; Sinha BP; Imam N
    Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, treatment, and outcomes of coexistent ocular surface squamous neoplasia and pterygium.
    Oellers P; Karp CL; Sheth A; Kao AA; Abdelaziz A; Matthews JL; Dubovy SR; Galor A
    Ophthalmology; 2013 Mar; 120(3):445-450. PubMed ID: 23107578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study.
    Galor A; Karp CL; Chhabra S; Barnes S; Alfonso EC
    Br J Ophthalmol; 2010 May; 94(5):551-4. PubMed ID: 19493859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of topical 5-fluorouracil in conjunctival intraepithelial neoplasia refractory to interferon alpha-2b.
    Pérez-García P; Burgos-Blasco B; Gómez-Calleja V; Vidal-Villegas B; Méndez-Fernández R; Gegúndez-Fernández JA; Díaz-Valle D
    J Oncol Pharm Pract; 2023 Jun; 29(4):975-979. PubMed ID: 36131486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical chemotherapy for ocular surface squamous neoplasia.
    Nanji AA; Sayyad FE; Karp CL
    Curr Opin Ophthalmol; 2013 Jul; 24(4):336-42. PubMed ID: 23680759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b.
    Rocha-de-Lossada C; Alba-Linero C; Borroni D; Rachwani-Anil R; Zamorano-Martín F; Rodríguez-Calvo-de-Mora M
    Rom J Ophthalmol; 2020; 64(1):62-65. PubMed ID: 32292860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response.
    Kaliki S; Bejjanki KM; Desai A; Mohamed A
    Semin Ophthalmol; 2019; 34(7-8):465-472. PubMed ID: 31370766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
    Chaugule SS; Park J; Finger PT
    Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extending far and wide: the role of biopsy and staging in the management of ocular surface squamous neoplasia.
    Polski A; Sibug Saber M; Kim JW; Berry JL
    Clin Exp Ophthalmol; 2019 Mar; 47(2):193-200. PubMed ID: 30156057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia.
    Joag MG; Sise A; Murillo JC; Sayed-Ahmed IO; Wong JR; Mercado C; Galor A; Karp CL
    Ophthalmology; 2016 Jul; 123(7):1442-8. PubMed ID: 27030104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Complications in the treatment of ocular surface squamous neoplasia with interferon α‑2b in rheumatoid arthritis].
    Torres Suárez E; Pinheiro R; Schrage N
    Ophthalmologe; 2017 Feb; 114(2):155-158. PubMed ID: 27300720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.
    Karp CL; Galor A; Chhabra S; Barnes SD; Alfonso EC
    Ophthalmology; 2010 Dec; 117(12):2241-6. PubMed ID: 20619462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoreduction of ocular surface tumours with intralesional interferon alpha-2a.
    Kim SE; Salvi SM
    Eye (Lond); 2018 Feb; 32(2):460-462. PubMed ID: 28937145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pegylated interferon-alpha-2a for the treatment of ocular surface squamous neoplasia.
    Nuruddin M; Roy SR; Hoque F
    Oman J Ophthalmol; 2022; 15(1):81-84. PubMed ID: 35388258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical medical therapies for ocular surface tumors.
    Poothullil AM; Colby KA
    Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
    Schechter BA; Koreishi AF; Karp CL; Feuer W
    Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.